Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
about
Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinomaImpact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional dataTiming of cisplatin administration for chemoradiotherapy in transgenic mice bearing lens tumors.Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer.Radiosensitizers in cervical cancer. Cisplatin and beyond.Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.Radiation-sparing managements for cervical cancer: a developing countries perspective.The role of cisplatin alternative regimens with radiotherapy in cervical cancer.A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative studyTherapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer.[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.Use of an orthovoltage X-ray treatment unit as a radiation research system in a small-animal cancer modelBrachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patientsConcurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.Correlation between bone marrow dose volumes and acute hematological toxicity in postoperative gynecological cancer patients.Pharmacotherapy options for locally advanced and advanced cervical cancer.Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer.Cervical cancer: A comprehensive approach towards extermination.Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial.Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients.
P2860
Q25256293-65F25968-2B0A-4238-B5EC-48ADB7958B16Q33578833-AE227C4C-18A1-4149-9B74-44031E125D4AQ33793959-43200C20-74C6-4020-A99A-C3DC7E369844Q34009168-54E99331-5A61-4F40-89C3-1C6F25246AECQ34202723-E071889F-5DAC-438A-8B39-D291013CFA0FQ34684307-B7BAA99C-31E9-4053-B44B-452F7C49BEA7Q35082777-F7228FA4-9437-4877-A39C-8B9D00DE4EA5Q35165643-0127C503-5056-478A-B70D-DB1B4A88E508Q35614113-4991AFF3-DF10-4D32-ABDA-B1070AFC8C71Q35782691-3BDB1113-8B81-408A-8075-1C70DBA6C512Q35929653-C4EEE111-0A65-4768-B344-F8AC21DF9711Q36195902-B21106F9-70A6-44BA-BE63-3DF6EF2720A8Q36609751-0391E40C-A44B-483F-B319-ECA60A342CA4Q36980417-317B0D7F-5520-4543-B34C-A76FB17BEE74Q37114187-083DBB6D-61F4-463D-B567-90BA48036B8AQ37276706-4654F69D-0253-439D-8CA6-778049C0995AQ37563241-3D0D6187-3ABE-4D08-A80E-2502554DD991Q37703190-765C9847-9D8B-4A26-8E59-655BF2A7D157Q37939985-DCFC8516-F391-45E6-94EF-492478564259Q38748682-2C3F38F8-CE52-4066-A984-EBF7F9F8F49BQ39782477-10C871A7-EDD9-4776-8F9B-096042E1507EQ46900917-45C40B29-0ED0-436E-AB1B-5A80BBD9D9EF
P2860
Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Pathologic response and toxici ...... : a randomized Phase II study.
@en
Pathologic response and toxici ...... : a randomized Phase II study.
@nl
type
label
Pathologic response and toxici ...... : a randomized Phase II study.
@en
Pathologic response and toxici ...... : a randomized Phase II study.
@nl
prefLabel
Pathologic response and toxici ...... : a randomized Phase II study.
@en
Pathologic response and toxici ...... : a randomized Phase II study.
@nl
P2093
P1476
Pathologic response and toxici ...... : a randomized Phase II study.
@en
P2093
Aarón Gonzalez-Enciso
Alejandro Mohar
Alfonso Dueñas-González
Carlos Lopez-Graniel
David Muñoz-Gonzalez
Elisa Vazquez-Govea
Ernesto Gómez-Gonzalez
Gonzalo Montalvo-Esquivel
Jaime de La Garza
Juan Robles-Flores
P304
P356
10.1016/J.IJROBP.2004.07.676
P407
P577
2005-03-01T00:00:00Z